US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

ArriVent BioPharma

22.05

-0.6700-2.95%

Post-market: 22.050.00000.00%16:04 EDT

Volume:316.53K

Turnover:7.08M

Market Cap:805.35M

PE:-5.83

High:23.38

Open:23.02

Low:21.95

Close:22.72

Loading ...

Overview Company News Filings

ArriVent BioPharma, Inc.: Promising Developments and Strategic Advancements Drive Buy Rating

ArriVent BioPharma Price Target Announced at $33.00/Share by Goldman Sachs

ArriVent BioPharma, Inc. (AVBP) Receives a Buy from Goldman Sachs

ArriVent BioPharma Announces $75 Million Public Offering

ArriVent Biopharma Files Prospectus for $75 Million Public Offering of Common Stock and Pre-Funded Warrants

BUZZ-U.S. STOCKS ON THE MOVE-Investar, Steel Dynamics, Axos Financial

BUZZ-U.S. STOCKS ON THE MOVE-Zevra Therapeutics, Abeona Therapeutics, Greenbrier

BUZZ-ArriVent BioPharma drops after $75 mln equity raise

Arrivent Announces Pricing of $75 Million Public Offering of Common Stock and Pre-Funded Warrants

THOMSON REUTERS

ArriVent BioPharma Plans $75 Million Public Offering

MT Newswires Live

Arrivent Biopharma Shares Down 8.5% at $19.11 After the Bell Following Stock Offer Announcement

THOMSON REUTERS

BRIEF-Arrivent Proposes $75 Million Public Offering of Common Stock and Pre-Funded Warrants

Arrivent Announces Proposed $75 Million Public Offering of Common Stock and Pre-Funded Warrants

THOMSON REUTERS

Wall Street Analysts Are Bullish on Top NA Picks

ArriVent BioPharma Initiated at Buy by Clear Street

ArriVent Biopharma initiated with a Buy at Clear Street

ArriVent BioPharma Price Target Maintained With a $45.00/Share by Guggenheim

Analysts Offer Insights on NA Companies: Reddit Inc Class A (RDDT), ArriVent BioPharma, Inc. (AVBP) and Fractyl Health, Inc. (GUTS)

ArriVent BioPharma Reports Positive Phase 1b Study Results

ArriVent BioPharma’s Firmonertinib Shows Promise in NSCLC Treatment with Strong Phase 1b Results and Strategic Phase 3 Plans

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/AVBP/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AVBP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AVBP\",,,,,undefined,":{"symbol":"AVBP","market":"US","secType":"STK","nameCN":"ArriVent BioPharma","latestPrice":22.05,"timestamp":1752868800000,"preClose":22.72,"halted":0,"volume":316531,"hourTrading":{"tag":"盘后","latestPrice":22.05,"preClose":22.05,"latestTime":"16:04 EDT","volume":4489,"amount":98984.34884699999,"timestamp":1752869048052},"delay":0,"floatShares":18132962,"shares":36523688,"eps":-3.784111,"marketStatus":"Post-Mkt","change":-0.67,"latestTime":"07-18 18:20:45 EDT","open":23.02,"high":23.3757,"low":21.95,"amount":7080361.1023,"amplitude":0.062751,"askPrice":24.8,"askSize":100,"bidPrice":21.7,"bidSize":159,"shortable":3,"etf":0,"ttmEps":-3.784111,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1752883200000},"marketStatusCode":4,"adr":0,"listingDate":1706245200000,"exchange":"NASDAQ","adjPreClose":22.72,"preHourTrading":{"tag":"盘前","latestPrice":23.49,"preClose":22.72,"latestTime":"09:29 EDT","volume":619,"amount":14354.180413999999,"timestamp":1752845382392},"postHourTrading":{"tag":"盘后","latestPrice":22.05,"preClose":22.05,"latestTime":"16:04 EDT","volume":4489,"amount":98984.34884699999,"timestamp":1752869048052},"volumeRatio":1.45716,"impliedVol":0.7777,"impliedVolPercentile":0.942},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AVBP\",,,,,undefined,":{"symbol":"AVBP","floatShares":18132962,"roa":"-23.10%","roe":"-49.00%","lyrEps":-2.557665,"volumeRatio":1.45716,"shares":36523688,"dividePrice":0,"high":23.3757,"amplitude":0.062751,"preClose":22.72,"low":21.95,"week52Low":15.47,"pbRate":"3.98","week52High":36.37,"institutionHeld":0,"latestPrice":22.05,"committee":0.227799,"eps":-3.784111,"divideRate":0,"volume":316531,"delay":0,"ttmEps":-3.784111,"open":23.02,"prevYearClose":26.64,"prevWeekClose":21.63,"prevMonthClose":21.77,"prevQuarterClose":21.77,"fiveDayClose":21.63,"twentyDayClose":24.89,"sixtyDayClose":20.28},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AVBP\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2552384488","title":"ArriVent BioPharma, Inc.: Promising Developments and Strategic Advancements Drive Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2552384488","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552384488?lang=en_us&edition=fundamental","pubTime":"2025-07-17 17:57","pubTimestamp":1752746221,"startTime":"0","endTime":"0","summary":"Citi analyst Yigal Nochomovitz has maintained their bullish stance on AVBP stock, giving a Buy rating on July 10. Yigal Nochomovitz has given his B...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/arrivent-biopharma-inc-promising-developments-and-strategic-advancements-drive-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/arrivent-biopharma-inc-promising-developments-and-strategic-advancements-drive-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVBP"],"gpt_icon":0},{"id":"2550678415","title":"ArriVent BioPharma Price Target Announced at $33.00/Share by Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2550678415","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550678415?lang=en_us&edition=fundamental","pubTime":"2025-07-11 02:24","pubTimestamp":1752171840,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AVBP/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  July 10, 2025 14:24 ET (18:24 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVBP"],"gpt_icon":0},{"id":"2550160526","title":"ArriVent BioPharma, Inc. (AVBP) Receives a Buy from Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2550160526","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550160526?lang=en_us&edition=fundamental","pubTime":"2025-07-10 15:35","pubTimestamp":1752132904,"startTime":"0","endTime":"0","summary":"Goldman Sachs analyst Corinne Johnson initiated coverage with a Buy rating on ArriVent BioPharma, Inc. today and set a price target of $33.00. The ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/arrivent-biopharma-inc-avbp-receives-a-buy-from-goldman-sachs-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/arrivent-biopharma-inc-avbp-receives-a-buy-from-goldman-sachs-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2471134879.HKD","LU2471134952.CNY","LU2750360641.GBP","BK4127","BK4588","LU0742534661.SGD","LU0048573561.USD","BK4585","LU2237443549.SGD","LU0061475181.USD","LU1868836914.USD","AVBP","LU2471134796.USD","LU1868837300.USD","LU0096364046.USD","LU1791807156.HKD","BK4516","LU1894683348.USD","BK4139","IE00B19Z3B42.SGD","IE00BSNM7G36.USD","LU2237443978.SGD","IE0004091025.USD","BK4504","BK4533","IE0002270589.USD","LU2237438978.USD","IE00BFXG1179.USD","LU0251142724.SGD","LU2237443465.HKD","IE0004086264.USD","LU1868837136.USD","LU1868836591.USD","LU2237443622.USD","LU2237443895.HKD","LU2471134523.USD","LU1868836757.USD","LU1894683264.USD","LU2237443382.USD","LU2750360997.AUD","BK4552","IE0034235188.USD","BK4550","LU0106831901.USD","IE00B19Z3581.USD","LU0251131958.USD","LU1668664300.SGD"],"gpt_icon":0},{"id":"2548866843","title":"ArriVent BioPharma Announces $75 Million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2548866843","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548866843?lang=en_us&edition=fundamental","pubTime":"2025-07-03 05:30","pubTimestamp":1751491846,"startTime":"0","endTime":"0","summary":"ArriVent BioPharma, Inc. ( ($AVBP) ) has shared an update. On July 1, 2025, ArriVent BioPharma, Inc. announced the pricing of an underwritten publi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/arrivent-biopharma-announces-75-million-public-offering?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/arrivent-biopharma-announces-75-million-public-offering?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","AVBP"],"gpt_icon":0},{"id":"2548484858","title":"ArriVent Biopharma Files Prospectus for $75 Million Public Offering of Common Stock and Pre-Funded Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2548484858","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548484858?lang=en_us&edition=fundamental","pubTime":"2025-07-03 05:01","pubTimestamp":1751490073,"startTime":"0","endTime":"0","summary":"ArriVent Biopharma Inc., a clinical-stage biopharmaceutical company, has announced the pricing of a $75 million public offering of common stock and pre-funded warrants. The company has filed an automatic shelf registration statement on Form S-3ASR with the SEC, which became effective upon filing on February 3, 2025. The offering includes 2,482,692 shares of common stock priced at $19.50 each and pre-funded warrants for an additional 1,363,469 shares. The proceeds are intended to support the company's pipeline programs and general corporate purposes. The offering, expected to close around July 3, 2025, is managed by Goldman Sachs, Citigroup, and Guggenheim Securities, among others.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ArriVent","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250702:nNDL3VqdP3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765646.SGD","LU0310800965.SGD","LU0106831901.USD","BK4533","BK4559","LU0048573561.USD","LU1868837136.USD","LU2237443895.HKD","LU0742534661.SGD","LU2236285917.USD","LU1868837300.USD","LU1366192091.USD","LU2237443382.USD","LU0098860793.USD","LU1267930227.SGD","BK4139","LU0170899867.USD","LU1668664300.SGD","LU1868836757.USD","LU1894683264.USD","LU2462157665.USD","BK4207","LU1894683348.USD","BK4550","LU0130517989.USD","LU2456880835.USD","LU1201861249.SGD","LU1868836591.USD","BK4566","LU0072461881.USD","LU2237443465.HKD","LU2360032135.SGD","IE00BFXG1179.USD","LU1791807156.HKD","LU0251142724.SGD","BK4127","BK4552","LU2125154935.USD","LU2237443549.SGD","LU2417539215.USD","LU0648001328.SGD","AVBP","BK4534","LU0096364046.USD","LU0477156953.USD","LU0162691827.USD","BK4504","IE0002270589.USD","IE0004086264.USD","IE0004091025.USD"],"gpt_icon":0},{"id":"2548141158","title":"BUZZ-U.S. STOCKS ON THE MOVE-Investar, Steel Dynamics, Axos Financial","url":"https://stock-news.laohu8.com/highlight/detail?id=2548141158","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548141158?lang=en_us&edition=fundamental","pubTime":"2025-07-03 02:00","pubTimestamp":1751479228,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Investar, Steel Dynamics, Axos FinancialEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsl","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250702:nL6N3SZ0DA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REGN","APA","GBX","ABEO","ALV","AVBP","PRMB","NUE","ISTR","ANF","OMDA","FCX","SPOT","JBL","VRNT","ABM","EQT","ZVRA","ELV","CAVA","UAA","STZ","OGN","DFDV","CNC","VFC","CARG","CVNA","DNTH","KBR","SCCO","AX","FSLR","CVX","GEV","MO","RIVN","ROST","XOM","STLD","BMRC"],"gpt_icon":1},{"id":"2548897651","title":"BUZZ-U.S. STOCKS ON THE MOVE-Zevra Therapeutics, Abeona Therapeutics, Greenbrier","url":"https://stock-news.laohu8.com/highlight/detail?id=2548897651","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548897651?lang=en_us&edition=fundamental","pubTime":"2025-07-02 21:10","pubTimestamp":1751461853,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Zevra Therapeutics, Abeona Therapeutics, GreenbrierEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250702:nL6N3SZ0D7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2746668461.USD","XOM","LU1267930227.SGD","LU0823434740.USD","LU2125154935.USD","STZ","CAVA","BHP.AU","LU0122376428.USD","ZVRA","CVNA","OMDA","EQT","CNC","LU0149725797.USD","ABEO","OGN","LU2213496289.HKD","ALV","ELV","LU2028103732.USD","LU2108987350.USD","RIO.AU","ROST","LU1551013425.SGD","LU2290526834.HKD","LU0612318385.USD","DFDV","LU1084165304.USD","SPOT","LU1883866441.USD","IE00BQXX3D17.EUR","SCCO","JBL","MO","LU0738911758.USD","LU2324357040.USD","RIO.UK","APA","LU2430703251.USD","FCX","GBX","CVX","AVBP","BK4507"],"gpt_icon":1},{"id":"2548889959","title":"BUZZ-ArriVent BioPharma drops after $75 mln equity raise","url":"https://stock-news.laohu8.com/highlight/detail?id=2548889959","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548889959?lang=en_us&edition=fundamental","pubTime":"2025-07-02 19:25","pubTimestamp":1751455515,"startTime":"0","endTime":"0","summary":"BUZZ-ArriVent BioPharma drops after $75 mln equity raise** ArriVent BioPharma's AVBP.O shares down 4.3% premarket at $20 after overnight follow-on priced** Newtown Square, Pennsylvania-based late Tues announced ~3.8 mln shares, including pre-funded warrants to buy ~1.4 mln shares, for $75 mln gross proceeds** Offering price of $19.50 is 6.7% discount to stock's last sale** Co to use net proceeds to support activities for lead candidate, firmonertinib, its treatment for non-small cell lung cancer, and other pipeline programs, among other general purposes** Goldman Sachs, Citigroup and Guggenheim are jt bookrunners for offering** ArriVent has ~34.2 mln shares outstanding for ~$715 mln market cap** AVBP shares on Tues fell 4% to $20.89, stretching YTD loss to ~22%** All 8 analysts are bullish on AVBP with avg rating of \"strong buy\" and median PT is $40, latest LSEG data reflects","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250702:nL6N3SZ0G7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","LU0130102774.USD","LU0980610538.SGD","LU1201861249.SGD","LU0106831901.USD","LU2471134796.USD","LU2237443382.USD","LU2237443622.USD","BK4552","LU2125154935.USD","LU2236285917.USD","LU0052756011.USD","BK4585","LU2237443549.SGD","LU0098860793.USD","LU1868837136.USD","BK4588","BK4550","LU2750360641.GBP","BK4516","LU0477156953.USD","LU1267930227.SGD","LU0162691827.USD","LU2237443465.HKD","BK4127","AVBP","LU0251131958.USD","IE0004091025.USD","LU1366192091.USD","LU2360032135.SGD","BK4559","LU0648001328.SGD","LU1791807156.HKD","LU2471134523.USD","LU0320765646.SGD","LU0170899867.USD","LU0310800965.SGD","LU2237438978.USD","LU0096364046.USD","LU1868836757.USD","LU1894683264.USD","LU1868836591.USD","LU1894683348.USD","BK4139","LU0130517989.USD","LU2417539215.USD","LU0742534661.SGD","IE00BSNM7G36.USD","IE0034235188.USD","LU0061475181.USD"],"gpt_icon":0},{"id":"2548853776","title":"Arrivent Announces Pricing of $75 Million Public Offering of Common Stock and Pre-Funded Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2548853776","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548853776?lang=en_us&edition=fundamental","pubTime":"2025-07-02 11:15","pubTimestamp":1751426112,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250702:nTUA2PZF68:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","AVBP"],"gpt_icon":0},{"id":"2548865887","title":"ArriVent BioPharma Plans $75 Million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2548865887","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548865887?lang=en_us&edition=fundamental","pubTime":"2025-07-02 04:24","pubTimestamp":1751401496,"startTime":"0","endTime":"0","summary":"ArriVent BioPharma  said late Tuesday it plans a $75 million public offering of common shares and pre-funded warrants.The company said it will offer underwriters a 30-day overallotment option to buy up to an additional 15% of the total offering size.ArriVent will use the net proceeds to advance activities related to its firmonertinib drug to treat non-squamous non-small cell lung cancer, as well as for general corporate purposes, the company said.Shares of the company fell 5.7% during after-hours activity.Price: 19.70, Change: -1.19, Percent Change: -5.70","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","AVBP"],"gpt_icon":0},{"id":"2548882223","title":"Arrivent Biopharma Shares Down 8.5% at $19.11 After the Bell Following Stock Offer Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=2548882223","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548882223?lang=en_us&edition=fundamental","pubTime":"2025-07-02 04:15","pubTimestamp":1751400928,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250701:nL1N3SY0ZI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","AVBP"],"gpt_icon":0},{"id":"2548444882","title":"BRIEF-Arrivent Proposes $75 Million Public Offering of Common Stock and Pre-Funded Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2548444882","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548444882?lang=en_us&edition=fundamental","pubTime":"2025-07-02 04:11","pubTimestamp":1751400701,"startTime":"0","endTime":"0","summary":"BRIEF-Arrivent Proposes $75 Million Public Offering of Common Stock and Pre-Funded WarrantsJuly 1 (Reuters) - Arrivent Biopharma Inc AVBP.O:ARRIVENT ANNOUNCES PROPOSED $75 MILLION PUBLIC OFFERING OF C","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250701:nTUA2QT3PW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AVBP"],"gpt_icon":0},{"id":"2548882990","title":"Arrivent Announces Proposed $75 Million Public Offering of Common Stock and Pre-Funded Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2548882990","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548882990?lang=en_us&edition=fundamental","pubTime":"2025-07-02 04:05","pubTimestamp":1751400300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250701:nTUA2QT3PW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","AVBP"],"gpt_icon":0},{"id":"2547720098","title":"Wall Street Analysts Are Bullish on Top NA Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2547720098","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547720098?lang=en_us&edition=fundamental","pubTime":"2025-06-30 18:40","pubTimestamp":1751280012,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the NA sector as 2 analysts just weighed in on ArriVent BioPharma, Inc. (AVBP – Research Report) and Waysta...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-na-picks-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-na-picks-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVBP","BK4139","BK4141"],"gpt_icon":0},{"id":"2546401872","title":"ArriVent BioPharma Initiated at Buy by Clear Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2546401872","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546401872?lang=en_us&edition=fundamental","pubTime":"2025-06-26 01:37","pubTimestamp":1750873020,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AVBP/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 25, 2025 13:37 ET (17:37 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AVBP"],"gpt_icon":0},{"id":"2546253263","title":"ArriVent Biopharma initiated with a Buy at Clear Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2546253263","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546253263?lang=en_us&edition=fundamental","pubTime":"2025-06-25 04:30","pubTimestamp":1750797012,"startTime":"0","endTime":"0","summary":"Clear Street analyst Kaveri Pohlman initiated coverage of ArriVent Biopharma (AVBP) with a Buy rating and $32 price target Firmonertinib, ArriVent’...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/arrivent-biopharma-initiated-with-a-buy-at-clear-street-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/arrivent-biopharma-initiated-with-a-buy-at-clear-street-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVBP","BK4139"],"gpt_icon":0},{"id":"2545287189","title":"ArriVent BioPharma Price Target Maintained With a $45.00/Share by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2545287189","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545287189?lang=en_us&edition=fundamental","pubTime":"2025-06-24 20:48","pubTimestamp":1750769280,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AVBP/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 24, 2025 08:48 ET (12:48 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVBP"],"gpt_icon":0},{"id":"2545284160","title":"Analysts Offer Insights on NA Companies: Reddit Inc Class A (RDDT), ArriVent BioPharma, Inc. (AVBP) and Fractyl Health, Inc. (GUTS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2545284160","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545284160?lang=en_us&edition=fundamental","pubTime":"2025-06-24 19:50","pubTimestamp":1750765840,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the NA sector as 3 analysts just weighed in on Reddit Inc Class A (RDDT – Research Report), ArriVent BioPha...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-reddit-inc-class-a-rddt-arrivent-biopharma-inc-avbp-and-fractyl-health-inc-guts-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-reddit-inc-class-a-rddt-arrivent-biopharma-inc-avbp-and-fractyl-health-inc-guts-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4141","BK4082","LU1861215975.USD","LU1861220033.SGD","BK4547","GUTS","LU2290526834.HKD","RDDT","NA","AVBP","LU2360107168.USD","BK4077","BK4139"],"gpt_icon":0},{"id":"2545694444","title":"ArriVent BioPharma Reports Positive Phase 1b Study Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2545694444","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545694444?lang=en_us&edition=fundamental","pubTime":"2025-06-24 02:27","pubTimestamp":1750703259,"startTime":"0","endTime":"0","summary":"An announcement from ArriVent BioPharma, Inc. ( ($AVBP) ) is now available. On June 23, 2025, ArriVent BioPharma announced positive interim data fr...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/arrivent-biopharma-reports-positive-phase-1b-study-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/arrivent-biopharma-reports-positive-phase-1b-study-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","AVBP"],"gpt_icon":0},{"id":"2545611444","title":"ArriVent BioPharma’s Firmonertinib Shows Promise in NSCLC Treatment with Strong Phase 1b Results and Strategic Phase 3 Plans","url":"https://stock-news.laohu8.com/highlight/detail?id=2545611444","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545611444?lang=en_us&edition=fundamental","pubTime":"2025-06-24 02:25","pubTimestamp":1750703116,"startTime":"0","endTime":"0","summary":"In a report released today, Sam Slutsky from LifeSci Capital maintained a Buy rating on ArriVent BioPharma, Inc. (AVBP – Research Report), with a p...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/arrivent-biopharmas-firmonertinib-shows-promise-in-nsclc-treatment-with-strong-phase-1b-results-and-strategic-phase-3-plans-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/arrivent-biopharmas-firmonertinib-shows-promise-in-nsclc-treatment-with-strong-phase-1b-results-and-strategic-phase-3-plans-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","AVBP"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":53,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AVBP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-12","symbol":"AVBP","fiscalQuarterEnding":"2025/03","expectedEps":-0.66,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"pre","actualEps":-1.9},{"market":"US","date":"2025-03-03","symbol":"AVBP","fiscalQuarterEnding":"2024/12","expectedEps":-0.78,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740978000000,"reportTimeType":"pre","actualEps":-0.6},{"market":"US","date":"2024-11-14","symbol":"AVBP","fiscalQuarterEnding":"2024/09","expectedEps":-0.82,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"pre","actualEps":-0.61}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AVBP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AVBP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4444,"buy":0.5556,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5556,"analysts":9,"updateTime":1752206400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AVBP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AVBP","date":"2025-07-17","current":-6.275548,"percent":0.902857,"low":-15.980041,"twenty":-11.741287,"median":-10.153064,"eighty":-7.81452,"high":-5.032917,"avg":-9.76606,"sd":2.306948,"marketCap":799868767},"quantilePoints":[{"date":"2024-01-26","current":-15.452095,"twenty":-15.452095,"median":-15.452095,"eighty":-15.452095,"marketCap":905214654},{"date":"2024-02-02","current":-11.990156,"twenty":-12.001066,"median":-11.872873,"eighty":-10.91006,"marketCap":702407320},{"date":"2024-02-09","current":-12.548731,"twenty":-12.548731,"median":-12.001066,"eighty":-11.75559,"marketCap":735129780},{"date":"2024-02-16","current":-12.588659,"twenty":-12.548731,"median":-12.126596,"eighty":-11.919241,"marketCap":737468829},{"date":"2024-02-23","current":-11.219707,"twenty":-12.556717,"median":-11.998256,"eighty":-11.67237,"marketCap":657272853},{"date":"2024-03-01","current":-12.286349,"twenty":-12.548731,"median":-11.990156,"eighty":-11.204877,"marketCap":719758884},{"date":"2024-03-08","current":-11.464977,"twenty":-12.548731,"median":-11.964074,"eighty":-11.315533,"marketCap":671641299},{"date":"2024-03-15","current":-10.59227,"twenty":-12.5031,"median":-11.767288,"eighty":-11.121598,"marketCap":620516364},{"date":"2024-03-22","current":-10.386927,"twenty":-12.327418,"median":-11.658912,"eighty":-10.920492,"marketCap":608486967},{"date":"2024-03-28","current":-10.267144,"twenty":-12.279504,"median":-11.507757,"eighty":-10.718898,"marketCap":601469820},{"date":"2024-04-05","current":-8.84046,"twenty":-12.261251,"median":-11.265338,"eighty":-10.410884,"marketCap":612935625},{"date":"2024-04-12","current":-8.536116,"twenty":-12.10149,"median":-11.165519,"eighty":-9.961411,"marketCap":591834562},{"date":"2024-04-19","current":-7.487821,"twenty":-11.997694,"median":-11.025772,"eighty":-8.805678,"marketCap":519153125},{"date":"2024-04-26","current":-7.507145,"twenty":-11.992272,"median":-10.91658,"eighty":-8.501334,"marketCap":520492875},{"date":"2024-05-03","current":-8.115832,"twenty":-11.986485,"median":-10.803317,"eighty":-8.191193,"marketCap":562695000},{"date":"2024-05-10","current":-8.079495,"twenty":-11.960082,"median":-10.543786,"eighty":-8.115832,"marketCap":602552562},{"date":"2024-05-17","current":-9.049573,"twenty":-11.929189,"median":-10.386927,"eighty":-8.101297,"marketCap":674899062},{"date":"2024-05-24","current":-8.479203,"twenty":-11.828069,"median":-10.210104,"eighty":-8.115832,"marketCap":632362000},{"date":"2024-05-31","current":-8.739687,"twenty":-11.762609,"median":-9.361752,"eighty":-8.133223,"marketCap":651788375},{"date":"2024-06-07","current":-8.241175,"twenty":-11.7192,"median":-8.959751,"eighty":-8.180566,"marketCap":614610312},{"date":"2024-06-14","current":-8.456747,"twenty":-11.662334,"median":-8.912923,"eighty":-8.216398,"marketCap":630687312},{"date":"2024-06-21","current":-7.455231,"twenty":-11.653208,"median":-8.84046,"eighty":-8.15931,"marketCap":555996250},{"date":"2024-06-28","current":-7.81452,"twenty":-11.61214,"median":-8.79358,"eighty":-8.133223,"marketCap":582791250},{"date":"2024-07-05","current":-8.205246,"twenty":-11.533425,"median":-8.753505,"eighty":-8.152944,"marketCap":611930812},{"date":"2024-07-12","current":-8.268121,"twenty":-11.43988,"median":-8.706383,"eighty":-8.152944,"marketCap":616619937},{"date":"2024-07-15","current":-8.259139,"twenty":-11.414782,"median":-8.695535,"eighty":-8.154535,"marketCap":615950062},{"date":"2024-08-02","current":-9.655872,"twenty":-11.389685,"median":-8.706383,"eighty":-8.156127,"marketCap":720115625},{"date":"2024-08-09","current":-10.262171,"twenty":-11.294999,"median":-8.753505,"eighty":-8.186872,"marketCap":765332187},{"date":"2024-08-16","current":-10.701201,"twenty":-11.237959,"median":-8.81702,"eighty":-8.205246,"marketCap":801359406},{"date":"2024-08-23","current":-10.705686,"twenty":-11.199173,"median":-8.912923,"eighty":-8.209568,"marketCap":801695265},{"date":"2024-08-30","current":-12.010819,"twenty":-11.389685,"median":-8.993434,"eighty":-8.224295,"marketCap":899430214},{"date":"2024-09-06","current":-11.93009,"twenty":-11.657877,"median":-9.253918,"eighty":-8.235785,"marketCap":893384753},{"date":"2024-09-13","current":-10.669806,"twenty":-11.694732,"median":-9.655872,"eighty":-8.248361,"marketCap":799008394},{"date":"2024-09-20","current":-10.85369,"twenty":-11.663166,"median":-9.763659,"eighty":-8.262732,"marketCap":812778610},{"date":"2024-09-27","current":-10.544226,"twenty":-11.657877,"median":-10.060071,"eighty":-8.269917,"marketCap":789604344},{"date":"2024-10-04","current":-11.49056,"twenty":-11.61214,"median":-10.208101,"eighty":-8.279798,"marketCap":860470578},{"date":"2024-10-11","current":-12.463804,"twenty":-11.739278,"median":-10.315491,"eighty":-8.299559,"marketCap":933351966},{"date":"2024-10-18","current":-13.002004,"twenty":-11.938503,"median":-10.371883,"eighty":-8.317243,"marketCap":973655038},{"date":"2024-10-25","current":-13.912458,"twenty":-11.99333,"median":-10.426855,"eighty":-8.325491,"marketCap":1041834400},{"date":"2024-10-31","current":-14.114283,"twenty":-12.114871,"median":-10.539741,"eighty":-8.328911,"marketCap":1056948052},{"date":"2024-11-08","current":-15.980041,"twenty":-12.249611,"median":-10.573379,"eighty":-8.330997,"marketCap":1196665367},{"date":"2024-11-15","current":-11.674764,"twenty":-12.282511,"median":-10.59227,"eighty":-8.332793,"marketCap":946216280},{"date":"2024-11-22","current":-11.05527,"twenty":-12.272349,"median":-10.669806,"eighty":-8.342492,"marketCap":896007510},{"date":"2024-11-29","current":-12.456408,"twenty":-12.274941,"median":-10.685503,"eighty":-8.352544,"marketCap":1009566943},{"date":"2024-12-06","current":-11.870175,"twenty":-12.284404,"median":-10.712096,"eighty":-8.353452,"marketCap":962053946},{"date":"2024-12-13","current":-10.760075,"twenty":-12.274941,"median":-10.748293,"eighty":-8.371867,"marketCap":872082526},{"date":"2024-12-20","current":-10.664448,"twenty":-12.261979,"median":-10.759506,"eighty":-8.380399,"marketCap":864332179},{"date":"2024-12-27","current":-11.46688,"twenty":-12.254096,"median":-10.803317,"eighty":-8.380399,"marketCap":929367700},{"date":"2025-01-03","current":-11.421146,"twenty":-12.244582,"median":-10.85369,"eighty":-8.380399,"marketCap":925661012},{"date":"2025-01-10","current":-11.167527,"twenty":-12.234172,"median":-10.860965,"eighty":-8.382195,"marketCap":905105744},{"date":"2025-01-17","current":-10.177999,"twenty":-12.217129,"median":-10.850538,"eighty":-8.390279,"marketCap":824906501},{"date":"2025-01-24","current":-11.329677,"twenty":-12.196013,"median":-10.850538,"eighty":-8.405549,"marketCap":918247637},{"date":"2025-01-31","current":-12.09469,"twenty":-12.164539,"median":-10.860965,"eighty":-8.437266,"marketCap":980250413},{"date":"2025-02-07","current":-11.383727,"twenty":-12.161213,"median":-10.897572,"eighty":-8.450678,"marketCap":922628268},{"date":"2025-02-14","current":-11.16337,"twenty":-12.157147,"median":-10.9231,"eighty":-8.461238,"marketCap":904768772},{"date":"2025-02-21","current":-11.387884,"twenty":-12.140884,"median":-10.92545,"eighty":-8.479203,"marketCap":922965239},{"date":"2025-02-28","current":-9.8537,"twenty":-12.107163,"median":-10.91658,"eighty":-8.519623,"marketCap":798622715},{"date":"2025-03-07","current":-9.217439,"twenty":-12.09469,"median":-10.885085,"eighty":-8.536116,"marketCap":741893256},{"date":"2025-03-14","current":-9.192082,"twenty":-12.065586,"median":-10.857328,"eighty":-8.618427,"marketCap":739852284},{"date":"2025-03-21","current":-8.258082,"twenty":-12.010819,"median":-10.847386,"eighty":-8.519623,"marketCap":664676489},{"date":"2025-03-28","current":-7.848136,"twenty":-12.001066,"median":-10.781696,"eighty":-8.449161,"marketCap":631680778},{"date":"2025-04-04","current":-7.159258,"twenty":-11.995446,"median":-10.737081,"eighty":-8.380399,"marketCap":576234377},{"date":"2025-04-11","current":-7.125448,"twenty":-11.990156,"median":-10.711139,"eighty":-8.353452,"marketCap":573513081},{"date":"2025-04-17","current":-7.564978,"twenty":-11.988746,"median":-10.703443,"eighty":-8.330997,"marketCap":608889926},{"date":"2025-04-25","current":-8.94696,"twenty":-11.984909,"median":-10.669806,"eighty":-8.330476,"marketCap":720122890},{"date":"2025-05-02","current":-8.908923,"twenty":-11.976101,"median":-10.6604,"eighty":-8.330997,"marketCap":717061432},{"date":"2025-05-09","current":-8.353948,"twenty":-11.95416,"median":-10.580862,"eighty":-8.330997,"marketCap":672392561},{"date":"2025-05-16","current":-5.164444,"twenty":-11.945123,"median":-10.566696,"eighty":-8.323142,"marketCap":658249673},{"date":"2025-05-23","current":-5.537551,"twenty":-11.932894,"median":-10.539741,"eighty":-8.281274,"marketCap":705805133},{"date":"2025-05-30","current":-5.636867,"twenty":-11.923581,"median":-10.506711,"eighty":-8.258716,"marketCap":718463781},{"date":"2025-06-06","current":-6.29987,"twenty":-11.889801,"median":-10.45834,"eighty":-8.241176,"marketCap":802968806},{"date":"2025-06-13","current":-6.342817,"twenty":-11.86768,"median":-10.37894,"eighty":-8.205246,"marketCap":808442816},{"date":"2025-06-20","current":-6.681029,"twenty":-11.831093,"median":-10.360937,"eighty":-8.13004,"marketCap":851550643},{"date":"2025-06-27","current":-6.122711,"twenty":-11.774139,"median":-10.336565,"eighty":-8.056606,"marketCap":780388516},{"date":"2025-07-03","current":-5.951741,"twenty":-11.764948,"median":-10.291317,"eighty":-8.012114,"marketCap":758596999},{"date":"2025-07-11","current":-6.3128,"twenty":-11.752729,"median":-10.177999,"eighty":-7.877518,"marketCap":804616846},{"date":"2025-07-17","current":-6.275548,"twenty":-11.741287,"median":-10.153064,"eighty":-7.81452,"marketCap":799868767}],"updateTime":1752873864125}}}